Roderick Bronson
lecturer on pathology
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (1)
The MYC transcription factor requires MAX for DNA binding and widespread activation of gene expression in both normal and neoplastic cells. Surprisingly, inactivating mutations in MAX are associated with a subset of neuroendocrine cancers including pheochromocytoma, pituitary adenoma and small cell lung cancer. Neither the extent nor the mechanisms of MAX tumor suppression are well understood. Deleting Max across multiple mouse neuroendocrine tissues, we find Max inactivation alone produces pituitary adenomas while Max loss cooperates with Rb1 / Trp53 loss to accelerate medullary thyroid C-cell and pituitary adenoma development. In the thyroid tumor cell lines, MAX loss triggers a striking shift in genomic occupancy by other members of the MYC network (MNT, MLX, MondoA) supporting metabolism, survival and proliferation of neoplastic neuroendocrine cells. Our work reveals MAX as a broad suppressor of neuroendocrine tumorigenesis through its ability to maintain a balance of genomic occupancies among the diverse transcription factors in the MYC network. Teaser MAX inactivation deregulates multiple transcription factors to induce neuroendocrine cancers
Year:
2024
Collaborators (4)
Patrick Carroll
Staff Scientist
Fred Hutchinson Cancer Research Center
Arnaud Augert
Assistant Professor
Yale University
David MacPherson
Professor
Fred Hutch Cancer Center
Robert Eisenman
Fred Hutchinson Cancer Research Center
Make your next move.
Prepare your application
Review drafts before you send them.